Your browser doesn't support javascript.
Deaths in children and young people in England after SARS-CoV-2 infection during the first pandemic year.
Smith, Clare; Odd, David; Harwood, Rachel; Ward, Joseph; Linney, Mike; Clark, Matthew; Hargreaves, Dougal; Ladhani, Shamez N; Draper, Elizabeth; Davis, Peter J; Kenny, Simon E; Whittaker, Elizabeth; Luyt, Karen; Viner, Russell; Fraser, Lorna K.
  • Smith C; NHS England and NHS Improvement, London, UK. clare.smith107@nhs.net.
  • Odd D; Paediatric Intensive Care Unit, Bristol Royal Hospital for Children, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK. clare.smith107@nhs.net.
  • Harwood R; Division of Population Medicine, Cardiff University, Cardiff, Wales, UK.
  • Ward J; National Child Mortality Database, University of Bristol, Bristol, UK.
  • Linney M; Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK.
  • Clark M; Department of Paediatric Surgery, Alder Hey in the Park, Liverpool, UK.
  • Hargreaves D; Population, Policy and Practice Department, UCL Great Ormond St. Institute of Child Health, London, UK.
  • Ladhani SN; Royal College of Paediatrics and Child Health, London, UK.
  • Draper E; Department of Paediatrics, University Hospitals Sussex NHS Foundation Trust, Brighton, UK.
  • Davis PJ; NHS England and NHS Improvement, London, UK.
  • Kenny SE; School of Public Health, Imperial College London, London, UK.
  • Whittaker E; Immunisation and Countermeasures, Public Health England, London, UK.
  • Luyt K; Paediatric Infectious Diseases Research Group, St. George's University of London, London, UK.
  • Viner R; Paediatric Intensive Care Audit Network (PICANet), Department of Health Sciences, University of Leicester, Leicester, UK.
  • Fraser LK; NHS England and NHS Improvement, London, UK.
Nat Med ; 28(1): 185-192, 2022 01.
Article in English | MEDLINE | ID: covidwho-1514420
ABSTRACT
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is rarely fatal in children and young people (CYP, <18 years old), but quantifying the risk of death is challenging because CYP are often infected with SARS-CoV-2 exhibiting no or minimal symptoms. To distinguish between CYP who died as a result of SARS-CoV-2 infection and those who died of another cause but were coincidentally infected with the virus, we undertook a clinical review of all CYP deaths with a positive SARS-CoV-2 test from March 2020 to February 2021. The predominant SARS-CoV-2 variants were wild-type and Alpha. Here we show that, of 12,023,568 CYP living in England, 3,105 died, including 61 who were positive for SARS-CoV-2. Of these deaths, 25 were due to SARS-CoV-2 infection (mortality rate, two per million), including 22 due to coronavirus disease 2019-the clinical disease associated with SARS-CoV-2 infection-and 3 were due to pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2. In total, 99.995% of CYP with a positive SARS-CoV-2 test survived. CYP older than 10 years, Asian and Black ethnic backgrounds and comorbidities were over-represented in SARS-CoV-2-related deaths compared with other CYP deaths. These results are important for guiding decisions on shielding and vaccinating children. New variants might have different mortality risks and should be evaluated in a similar way.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Ethnicity / Systemic Inflammatory Response Syndrome / COVID-19 Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Long Covid / Vaccines / Variants Limits: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male / Infant, Newborn Country/Region as subject: Europa Language: English Journal: Nat Med Journal subject: Molecular Biology / Medicine Year: 2022 Document Type: Article Affiliation country: S41591-021-01578-1

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Ethnicity / Systemic Inflammatory Response Syndrome / COVID-19 Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Long Covid / Vaccines / Variants Limits: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male / Infant, Newborn Country/Region as subject: Europa Language: English Journal: Nat Med Journal subject: Molecular Biology / Medicine Year: 2022 Document Type: Article Affiliation country: S41591-021-01578-1